AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 58 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1,399 | -64.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 3,914 | -92.1% | 0.00% | – |
| Q1 2022 | $24,000 | -64.2% | 49,543 | -57.8% | 0.00% | – |
| Q4 2021 | $67,000 | +458.3% | 117,312 | +1575.9% | 0.00% | – |
| Q3 2021 | $12,000 | -14.3% | 7,000 | -16.4% | 0.00% | – |
| Q2 2021 | $14,000 | -46.2% | 8,374 | -46.1% | 0.00% | – |
| Q1 2021 | $26,000 | -90.1% | 15,541 | -90.6% | 0.00% | – |
| Q4 2020 | $263,000 | +3.5% | 165,148 | -37.6% | 0.00% | – |
| Q3 2020 | $254,000 | +104.8% | 264,840 | +35.4% | 0.00% | – |
| Q2 2020 | $124,000 | +1671.4% | 195,663 | +948.1% | 0.00% | – |
| Q1 2020 | $7,000 | -30.0% | 18,669 | +4.4% | 0.00% | – |
| Q4 2019 | $10,000 | +25.0% | 17,874 | +8.3% | 0.00% | – |
| Q3 2019 | $8,000 | -11.1% | 16,500 | -26.7% | 0.00% | – |
| Q2 2019 | $9,000 | -82.0% | 22,523 | -74.5% | 0.00% | – |
| Q1 2019 | $50,000 | +42.9% | 88,388 | -0.3% | 0.00% | – |
| Q4 2018 | $35,000 | +29.6% | 88,664 | +62.2% | 0.00% | – |
| Q3 2018 | $27,000 | -75.2% | 54,650 | +10.1% | 0.00% | – |
| Q2 2018 | $109,000 | -35.9% | 49,635 | -0.6% | 0.00% | – |
| Q1 2018 | $170,000 | +2.4% | 49,921 | +22.7% | 0.00% | – |
| Q4 2017 | $166,000 | +1283.3% | 40,671 | +113.7% | 0.00% | – |
| Q3 2017 | $12,000 | +20.0% | 19,033 | +4.1% | 0.00% | – |
| Q2 2017 | $10,000 | -47.4% | 18,283 | -19.8% | 0.00% | – |
| Q1 2017 | $19,000 | -5.0% | 22,783 | 0.0% | 0.00% | – |
| Q4 2016 | $20,000 | +5.3% | 22,783 | -16.7% | 0.00% | – |
| Q3 2016 | $19,000 | -50.0% | 27,359 | -8.6% | 0.00% | – |
| Q2 2016 | $38,000 | -37.7% | 29,924 | +10.4% | 0.00% | – |
| Q1 2016 | $61,000 | -71.0% | 27,111 | -54.9% | 0.00% | – |
| Q4 2015 | $210,000 | +76.5% | 60,064 | +45.0% | 0.00% | – |
| Q3 2015 | $119,000 | +83.1% | 41,411 | +50.4% | 0.00% | – |
| Q2 2015 | $65,000 | -68.4% | 27,527 | -0.1% | 0.00% | – |
| Q1 2015 | $206,000 | +274.5% | 27,542 | +70.6% | 0.00% | – |
| Q4 2014 | $55,000 | +223.5% | 16,147 | +227.4% | 0.00% | – |
| Q3 2014 | $17,000 | -77.6% | 4,932 | -46.3% | 0.00% | – |
| Q2 2014 | $76,000 | +85.4% | 9,188 | +41.5% | 0.00% | – |
| Q1 2014 | $41,000 | +485.7% | 6,492 | +549.2% | 0.00% | – |
| Q4 2013 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |